Category
Last month, the National Clinical Care Commission (NCCC) issued a 192-page report urging an overhaul of diabetes care and an…

Trying to engage audiences when writing about obtaining and wearing appropriate masks to prevent the spread of COVID-19 can be…

Shayla Love, a senior staff writer at Motherboard (the tech arm of Vice.com), has written several articles about psychedelic drugs used as mental…

AHCJ is proud to announce that Novi, the new membership portal, is scheduled to go live before the end of…

In December 2021, The U.S. Food and Drug Administration released draft guidance for industry and investigators about best practices for acquiring data…

After a record number of consumers signed up for health insurance coverage under the Affordable Care Act (ACA), Bob Herman…

Margarita Birnbaum, a Texas-based independent journalist, storyteller, federally certified court interpreter and translator, joins AHCJ as the new health equity…

In mid-January, New York Times reporter Rebecca Robbins shared her personal story of hunting down the antiviral Paxlovid to successfully treat her…

Medicare’s plan to restrict access temporarily to a controversial new Alzheimer’s drug is worth investigating. Expect to see a flurry…

One of the most persistent concerns about potential adverse effects from the COVID-19 vaccines has been whether they will affect…
